Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder, Major

Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.

283 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder, Major trial results

Completed

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

NCT00644982

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Cairns, Queensland, Australia
  • Pfizer Investigational Site Everton Park, Queensland, Australia
  • Pfizer Investigational Site North Cairns, Queensland, Australia
  • Pfizer Investigational Site Box Hill, Victoria, Australia
View all 14 locations
View Trial Details
Completed

Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression

NCT00928980

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pro Persona Arnhem, Gelderland, Netherlands
  • Pro Persona Ede, Gelderland, Netherlands
  • Radboud University Nijmegen Medical Center Nijmegen, Gelderland, Netherlands
  • Pro Persona Tiel, Gelderland, Netherlands
View all 13 locations
View Trial Details
Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

NCT02709746

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • US1369 Dothan, Alabama, United States
  • US1333 Tucson, Arizona, United States
  • US1310 Little Rock, Arkansas, United States
  • US1062 Costa Mesa, California, United States
View all 124 locations
View Trial Details
Completed

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

NCT03002077

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Harmonex, Inc. Dothan, Alabama, United States
  • NoesisPharma Phoenix, Arizona, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
View all 128 locations
View Trial Details
Completed

Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder

NCT02466477

Conditions
Behavior, Behavioral Symptoms, Depression, +4 more
Locations
  • Chatham-Kent Clinical Trials Research Center Chatham, Ontario, Canada
  • Hamilton Community Health Centre Family Health Organization Hamilton, Ontario, Canada
  • Hamilton Medical Research Group Hamilton, Ontario, Canada
  • St. Joseph's Healthcare Hamilton (SJHH) Hamilton, Ontario, Canada
View all 14 locations
View Trial Details

Related conditions